Lactobacillus Rhamnosus Sepsis in an Immunosuppressed Patient with Tuberculous Meningitis and Myeloradiculitis

Despite the advances of microbiology, immunology and pharmacology, tuberculosis (TB) remains a serious public health problem, particularly in poor countries. Portugal, which has reduced the incidence of the disease in 2009, had an incidence of new cases of about 27.0 per 100,000 inhabitants, a figure which surpasses the average in Europe (15/100,000 inhabitants) and also values considered of low endemicity (<20 cases/100,000 inhabitants) [1]. In patients about to undergo immunosuppressive and immunomodulatory therapy, the risk of reactivation of latent tuberculosis is high and therefore, screening is mandatory in order to avoid the evolution of the disease from latent to active, with severe forms often difficult to treat.